US equities |
SPCX $168.25 ▲+5.84% NVDA $237.39 ▲+1.47% MU $1,065.88 ▼-0.84% TSLA $378.69 ▲+2.19% MSFT $525.67 ▲+1.57% SNDK $1,711.91 ▼-0.47% INTC $117.03 ▼-1.93% META $743.65 ▲+2.14%
FinancialContent

Articles published by Vaccitech plc

News headline image
Vaccitech to Host KOL Webinar on Seeking a Functional Cure for Chronic Hepatitis B on September 20, 2023
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech Reports Second Quarter 2023 Financial Results and Recent Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech to Present Positive Final Data at EASL Congress for Phase 1b/2 HBV002 Study in Adults with Chronic Hepatitis B
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech Doses First Patient in PCA001, a Prostate Cancer Phase 1/2 Clinical Trial of VTP-850 Immunotherapeutic Candidate in Men with Rising PSA after Definitive Local Therapy
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech Presents Interim Data from Phase 1b/2 Study of VTP-200 at 35th Annual International Papillomavirus Conference (IPVC) Highlighting Favorable Tolerability and Immunogenicity Profile
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech Announces Positive Topline Final Data for HBV002 Study in People with Chronic Hepatitis B
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech Reports Full-Year 2022 Financial Results and an Update on Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech’s VTP-200 Ph 1b/2 Study Demonstrates Favorable Tolerability and Immunogenicity Profile at Interim Analysis in Women with Low-Grade Human Papillomavirus (HPV)-related Cervical Lesions
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech Appoints Industry Veteran, Nadège Pelletier, Ph.D., as Chief Scientific Officer
From Vaccitech plc
Via GlobeNewswire
Tickers VACC
News headline image
Vaccitech Reports Third Quarter 2022 Financial Results and Recent Corporate Developments
From Vaccitech plc
Via GlobeNewswire
Tickers VACC